Epidemiology and natural history

Viral Hepatitis

Volumn , Issue , 2007, Pages 583-592

  Rosina, Floriano ^a   Rizzetto, Mario ^b  

^a GRADENIGO HOSPITAL   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

Author keywords

Cirrhosis; Co infection; Endemic HDV infection; Epidemiology; Hepatitis delta virus (HDV)

Indexed keywords

EID: 84889839278     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470987131.ch37     Document Type: Chapter

References (87)

1. Rizzetto M, Canese MG, Arico S et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut 1977;18:997-1003.
2. Rizzetto M, Purcell RH, Gerin JL. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers. Lancet 1980;1:1215-18.
3. Salassa B, Daziano E, Bonino F et al. Serological diagnosis of hepatitis B and delta virus (HBV/HDV) coinfection. J Hepatol 1991;12:10-13.
4. Shattock AG, Finlay H, Hillary IB. Possible reactivation of hepatitis D with chronic delta antigenaemia by human immunodefi- ciency virus. Br Med J (Clin Res Ed) 1987;294:1656-7.
5. Grippon P, Ribiere O, Cadranel JF et al. Long-term delta antigenaemia without appearance of delta antibody in two immunodeficient patients. Lancet 1987;1:1031.
6. Smedile A, Dentico P, Zanetti A et al. Infection with the delta agent in chronic HBsAg carriers. Gastroenterology 1981;81:992-7.
7. Gaeta GB, Stroffolini T, Chiaramonte M et al. Chronic hepatitis D: a vanishing disease? An Italian multicenter study. Hepatology 2000;32:824-7.
8. Strauss E, Gayotto LC, da Silva LC et al Unexpected low prevalence of delta antibodies in the east Amazon region and Sao Paulo: evidence for regional differences in the epidemiology of delta hepatitis virus within Brazil. Trans R Soc Trop Med Hyg 1987;81:73-4.
9. Greenfield C, Farci P, Osidiana V et al. Hepatitis delta virus infection in Kenya. Its geographic and tribal distribution. Am J Epidemiol 1986;123:416-23.
10. Roggendorf M, Mai K, Thian G et al. Prevalence of hepatitis delta virus infection in different provinces of China. Prog Clin Biol Res 1987;234:487-91.
11. Hao LJ, Zhang YY. Preliminary study of delta-agent in liver tissue of patients with virus hepatitis B. Acta Acad Med Wuhan 1985;5:107-11.
12. Saracco G, Rosina F, Brunetto MR et al. Rapidly progressive HBsAg- positive hepatitis in Italy. The role of hepatitis delta virus infection. J Hepatol 1987;5:274-81.
13. Buitrago B, Popper H, Hadler SC et al. Specific histologic features of Santa Marta hepatitis: a severe form of hepatitis delta-virus infection in northern South America. Hepatology 1986;6:1285-91.
14. Krogsgaard K, Mathiesen LR, Aldershvile J et al. Delta infection and hepatitis B virus replication in Danish patients with fulminant hepatitis B. Scand J Infect Dis 1988;20:127-33.
15. Fonseca JC, Simonetti SR, Schatzmayr HG, Castejon MJ, Cesario AL, Simonetti JP. Prevalence of infection with hepatitis delta virus (HDV) among carriers of hepatitis B surface antigen in Amazonas State, Brazil. Trans R Soc Trop Med Hyg 1988;82:469-71.
16. Alkandari S, Mahbut S, Nordenfelt E, al-Nakib B, al-Nakib W. Fulminant viral hepatitis in Kuwait. Ann Trop Med Parasitol 1988;82:555-9.
17. Pasetti G, Calzetti C, Degli Antoni A, Ferrari C, Penna A, Fiaccadori F. Clinical features of hepatitis delta virus infection in a northern Italian area. Infection 1988;16:345-8.
18. Khuroo MS, Zargar SA, Mahajan R, Javid G, Lal R. An epidemic of hepatitis D in the foothills of the Himalayas in south Kashmir. J Hepatol 1988;7:151-6.
19. Croxson M, Ljunggren K, Woodfield G. Fulminant delta hepatitis in a young Samoan. NZ Med J 1989;102:419-20.
20. Hadler SC, De Monzon M, Ponzetto A et al. Delta virus infection and severe hepatitis. An epidemic in the Yucpa Indians of Venezuela. Ann Intern Med 1984;100:339-44.
21. Torres JR, Mondolfi A. Protracted outbreak of severe delta hepatitis:experience in an isolated Amerindian population of the Upper Orinoco basin. Rev Infect Dis 1991;13:52-5.
22. Popper H, Thung SN, Gerber MA et al. Histologic studies of severe delta agent infection in Venezuelan Indians. Hepatology 1983;3:906-12.
23. Lettau LA, Alfred HJ, Glew RH et al. Nosocomial transmission of delta hepatitis. Ann Intern Med 1986;104:631-5.
24. Ratner L. Delta hepatitis outbreak in a group of patients with leukemia. Ann Intern Med 1986;105:972.
25. Raimondo G, Smedile A, Gallo L, Balbo A, Ponzetto A, Rizzetto M. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts. Lancet 1982;1:249-51.
26. Dimitrakakis M, Waters MJ, Wootton AL, Gust ID. Epidemiology of hepatitis D virus (delta) infection in Melbourne over a 15-year period. Med J Aust 1986;145:128-30.
27. Lee SD, Wang JY, Wu JC, Chiang YT, Tsai YT, Lo KJ. Hepatitis B and D virus infection among drug abusers in Taiwan. J Med Virol 1986;20:247-52.
28. Lettau LA, McCarthy JG, Smith MH et al. Outbreak of severe hepatitis due to delta and hepatitis B viruses in parenteral drug abusers and their contacts. N Engl J Med 1987;317:1256-62.
29. Louisirirotchanakul S, Wasi C, Uneklabh C et al. High prevalence of delta virus infection in Thai intravenous drug abusers. Southeast Asian J Trop Med Public Health 1988;19:191-5.
30. Kreek MJ, Des Jarlais DC, Trepo CL, Novick DM, Abdul-Quader A, Raghunath J. Contrasting prevalence of delta hepatitis markers in parenteral drug abusers with and without AIDS. J Infect Dis 1990;162:538-41.
31. Stroffolini T, Ferrigno L, Cialdea L et al. Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group. J Hepatol 1994;21:1123-6.
32. Rosina F, Conoscitore P, Cuppone R et al. Changing pattern of chronic hepatitis D in southern Europe. Gastroenterology 1999;117:161-6.
33. Hadziyannis SJ, Dourakis SP, Papaioannou C, Alexopoulou A, Hadziyannis ES, Gioustozi A. Changing epidemiology and spreading modalities of hepatitis delta virus infection in Greece. Prog Clin Biol Res 1993;382:259-66.
34. Dusheiko GM, Brink BA, Conradie JD, Marimuthu T, Sher R. Regional prevalence of hepatitis B, delta, and human immunodeficiency virus infection in southern Africa: a large population survey. Am J Epidemiol 1989;129:138-45.
35. Abdool Karim SS, Windsor IM, Gopaul W. Low prevalence of delta hepatitis virus infection among blacks in Natal. S Afr Med J 1991;80:193-4.
36. Casey JL, Brown TL, Colan EJ, Wignall FS, Gerin JL. A genotype of hepatitis D virus that occurs in northern South America. Proc Natl Acad Sci USA 1993;90:9016-20.
37. Wu JC, Choo KB, Chen CM, Chen TZ, Huo TI, Lee SD. Genotyping of hepatitis D virus by restriction-fragment length polymorphism and relation to outcome of hepatitis D. Lancet 1995;346:939-41.
38. Niro GA, Smedile A, Andriulli A, Rizzetto M, Gerin JL, Casey JL. The predominance of hepatitis delta virus genotype I among chronically infected Italian patients. Hepatology 1997;25:728-34.
39. Shakil AO, Hadziyannis S, Hoofnagle JH, Di Bisceglie AM, Gerin JL, Casey JL. Geographic distribution and genetic variability of hepatitis delta virus genotype I. Virology 1997;234:160-7.
40. Wu JC, Huang IA, Huang YH, Chen JY, Sheen IJ. Mixed genotypes infection with hepatitis D virus. J Med Virol 1999;57:64-7.
41. Caredda F, Rossi E, d’Arminio Monforte A et al. Hepatitis B virus- associated coinfection and superinfection with delta agent:indistinguishable disease with different outcome. J Infect Dis 1985;151:925-8.
42. Buti M, Esteban R, Jardi R et al. Clinical and serological outcome of acute delta infection. J Hepatol 1987;5:59-64.
43. Lindh G, Mattsson L, von Sydow M, Weiland O. Acute hepatitis B and hepatitis D co-infection in the Stockholm region in the 1970s and 1980s - a comparison. Infection 1990;18:357-60.
44. Govindarajan S, Valinluck B, Peters L. Relapse of acute B viral hepatitis - role of delta agent. Gut 1986;27:19-22.
45. Smedile A, Farci P, Verme G et al. Influence of delta infection on severity of hepatitis B. Lancet 1982;2:945-7.
46. Govindarajan S, Chin KP, Redeker AG, Peters RL. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 1984;86:1417-20.
47. Saracco G, Macagno S, Rosina F, Rizzetto M. Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey. Ann Intern Med 1988;108:380-3.
48. Lefkowitch JH, Goldstein H, Yatto R, Gerber MA. Cytopathic liver injury in acute delta virus hepatitis. Gastroenterology 1987;92:1262-6.
49. Ottobrelli A, Marzano A, Smedile A et al. Patterns of hepatitis delta virus reinfection and disease in liver transplantation. Gastroenterology 1991;101:1649-55.
50. Netter HJ, Gerin JL, Tennant BC, Taylor JM. Apparent helperindependent infection of woodchucks by hepatitis delta virus and subsequent rescue with woodchuck hepatitis virus. J Virol 1994;68:5344-50.
51. Colombo M, Cambieri R, Rumi MG, Ronchi G, Del Ninno E, De Franchis R. Long-term delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 1983;85:235-9.
52. Sagnelli E, Piccinino F, Pasquale G, di Costanzo MG, Franzese R, Peinetti P. Delta agent infection: an unfavourable event in HBsAg positive chronic hepatitis. Liver 1984;4:170-6.
53. Fattovich G, Boscaro S, Noventa F et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987;155:931-5.
54. Villari D, Raimondo G, Smedile V et al. Hepatitis B-DNA replication and histological patterns in liver biopsy specimens of chronic HBsAg positive patients with and without hepatitis delta virus superinfection. J Clin Pathol 1989;42:689-93.
55. Weller IV, Karayiannis P, Lok AS et al. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut 1983;24:1061-3.
56. Govindarajan S, Kanel GC, Peters RL. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles area: its correlation with liver biopsy diagnosis. Gastroenterology 1983;85:160-2.
57. Rizzetto M, Verme G, Recchia S et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98:437-41.
58. Aricò S, Aragona M, Rizzetto M et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet 1985;2:356-8.
59. Sagnelli E, Felaco FM, Filippini P et al. Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis. Liver 1989;9:229-34
60. Farci P, Barbera C, Navone C et al. Infection with the delta agent in children. Gut 1985;26:4-7.
61. Gu X, Li Q, Wang Y. Clinical characteristics of the patients with hepatitis B combining hepatitis D infection. Zhonghua Gan Zang Bing Za Zhi 2001;9:34-6.
62. Abiad H, Ramani R, Currie JB, Hershow RC. The natural history of hepatitis D virus infection in Illinois state facilities for the developmentally disabled. Am J Gastroenterol 2001;96:534-40.
63. de Man RA, Sprey RP, Niesters HG et al. Survival and complications in a cohort of patients with anti-delta positive liver disease presenting in a tertiary referral clinic. J Hepatol 1995;23:662-7.
64. Di Marco V, Lo Iacono O, Cammà C et al. The long-term course of chronic hepatitis B. Hepatology 1999;30:257-64.
65. Huo T, Wu JC, Hwang SJ et al. Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study. Eur J Gastroenterol Hepatol 2000;12:687-93.
66. Hadziyannis SJ, Papaioannou C, Alexopoulou A. The role of the hepatitis delta virus in acute hepatitis and in chronic liver disease in Greece. Prog Clin Biol Res 1991;364:51-62.
67. Navascues CA, Rodriguez M, Sotorrio NG et al. Epidemiology of hepatitis D virus infection. Am J Gastroenterol 1995;90:1981-4.
68. Craxi A, Di Marco V, Lo Iacono O et al. The natural history of chronic HDV infection. Prog Clin Biol Res 1993;382:301-10.
69. Fattovich G, Giustina G, Christensen E et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep). Gut 2000;46:420-6.
70. Fagiuoli S, Leandro G, Bellati G et al. The Monotematica AISFOLT Study Group. Liver transplantation in Italy: preliminary 10-year report. Ital J Gastroenterol 1996;28:343-50.
71. Chen DS, Lai MY, Sung JL. Delta agent infection in patients with chronic liver diseases and hepatocellular carcinoma - an infrequent finding in Taiwan. Hepatology 1984;4:502-3.
72. Kew MC, Dusheiko GM, Hadziyannis SJ, Patterson A. Does delta infection play a part in the pathogenesis of hepatitis B virus related hepatocellular carcinoma? Br Med J (Clin Res Ed) 1984;288:1727.
73. Oliveri F, Brunetto MR, Baldi M et al. Hepatitis delta virus (HDV) infection and hepatocellular carcinoma (HCC). Prog Clin Biol Res 1991;364:217-22.
74. Wu JC, Chen TZ, Huang YS et al. Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction. Gastroenterology 1995;108:796-802.
75. Watanabe H, Nagayama K, Enomoto N et al. Chronic hepatitis delta virus infection with genotype IIb variant is correlated with progressive liver disease. J Gen Virol 2003;84:3275-89
76. Flodgren E, Bengtsson S, Knutsson M et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol 2000;38:3311-16.
77. Casey JL, Niro GA, Engle RE et al. Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F. J Infect Dis 1996;174:920-6.
78. Nakano T, Shapiro CN, Hadler SC et al. Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela. J Gen Virol 2001;82:2183-9.
79. Hsu SC, Syu WJ, Sheen IJ, Liu HT, Jeng KS, Wu JC. Varied assembly and RNA editing efficiencies between genotypes I and II hepatitis D virus and their implications. Hepatology 2002;35:665-72.
80. Smedile A, Rosina F, Saracco G et al Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D. Hepatology 1991;13:413-16.
81. Niro GA, Gravinese E, Martini E et al. Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies. Liver 2001;21:254-9.
82. Chen YC, Sheen IS, Chu CM, Liaw YF. Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection. Gastroenterology 2002;123:1084-9.
83. Govindarajan S, Cassidy WM, Valinluck B, Redeker AG. Interactions of HDV, HBV and HIV in chronic B and D infections and in reactivation of chronic D infection. Prog Clin Biol Res 1991;364:207-10.
84. Buti M, Jardi R, Allende H et al. Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections? J Med Virol 1996;49:66-9.
85. Jardi R, Rodriguez F, Buti M et al. Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001;34:404-10
86. Mathurin P, Thibault V, Kadidja K et al. Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections. J Viral Hepat 2000;7:15-22.
87. Lu SN, Chen TM, Lee CM, Wang JH, Tung HD, Wu JC. Molecular epidemiological and clinical aspects of hepatitis D virus in a unique triple hepatitis viruses (B, C, D) endemic community in Taiwan. J Med Virol 2003;70:74-80.